“Cycle has partnered with Intract Pharma Ltd to work with innovative new formulation technologies that will allow us to improve and repurpose drugs.”
CHIKAI LAI, Regulatory Affairs
Superior colonic release drug delivery technology
Colon-targeted delivery has several therapeutic advantages. For treating localised diseases, it can reduce doses and maximise the effect of the treatment. Many existing colonic delivery systems are highly variable in their release timing, whereas Phloral technology offers a reliable treatment for every patient.
Rapid release microparticulate formulation
ProRelease technology produces a fast-release microparticulate delivery system in which drugs are encapsulated in enteric polymers for pH-targeted delivery. ProRelease microparticles are an ideal size for oral delivery, and due to their versatility, they show considerable promise for the development of formulations suitable for paediatric and geriatric populations.
Phloral® and ProRelease® are registered trademarks of Intract Pharma Limited.